Activists and 5% owners

Item 4, purpose of the transaction: The Board of Directors (the "Board") is reporting beneficial ownership of 100,527,578 shares of Common Stock (the "Shares") held by the MetLife Policyholder Trust (the "Trust") under the Plan of Reorganization, dated September 28, 1999, as amended (the "Plan"), of Metropolitan Life Insurance Company ("MetLife"). On April 7, 2000, 494,466,664 Shares were issued to the Trust pursuant to Section 5.2(d) of the Plan, a copy of which is attached as an exhibit to this statement. No consideration has been separately provided therefor by any member of the Board, except for Shares allocated to such member pursuant to the Plan. Since April 7, 2000, transactions by Beneficiaries (i) under the Purchase …

Item 4, purpose of the transaction: The information set forth in Item 5(c) of this amendment to Schedule 13D is incorporated herein by reference.

Item 4, purpose of the transaction: The information contained in Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following information: The information contained in Item 6 of this Amendment No. 10 is incorporated by reference into this Item.

Item 4, purpose of the transaction: Item 4 is hereby deleted in its entirety and replaced with the following: The information set forth or incorporated in Item 3 and Item 6 of the Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. On October 8, 2026, CSI sold all 5,676,952 shares of Common Stock held by it in a block trade at a price of $8.39 per share. CSI effected the sale to liquidate their position. The Reporting Persons may in the future take actions with respect to their investment in the Issuer as they deem appropriate, including changing their current intentions, with respect to any or all matters required to be disclosed in this Schedule 13D. From time to time, the Reporting Persons…

Item 4, purpose of the transaction: Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The information set forth in Item 6 of this Amendment No. 1 is incorporated by reference into this Item 4.

Item 4, purpose of the transaction: The information with respect to the Suspension of the Share Repurchases forth in Item 5(c) is incorporated herein by reference to the extent responsive to this Item 4.

Item 4, purpose of the transaction: The information contained in Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following information: On September 23, 2026, People announced that it has withdrawn its previously submitted non-binding proposal to acquire all of the outstanding shares of Common Stock of the Issuer that are not owned by People, as described in Amendment No. 8 to this Schedule 13D. People announced that it remains open to and interested in the possibility of a strategic transaction with the Issuer and looks forward to considering a range of alternatives. The Reporting Person intends to review its investment in the Issuer on a continuing basis. Depending on various factors including,…

Item 4, purpose of the transaction: Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: As a result of the distribution of certain voting securities of LOR, Inc., Rollins Holding Company, Inc. and RFA Management Company, LLC to its beneficiary on September 17, 2026, the GWR Voting Trust is no longer the beneficial owner of the shares of Common Stock held indirectly by or through LOR, Inc., Rollins Holding Company, Inc., RFA Management Company, LLC, RCTLOR, LLC or RFT Investment Company, LLC.

Item 4, purpose of the transaction: The Share Transaction was for investment purposes. In compliance with the requirements of the Stockholders' Agreement, in connection with the Share Transaction, Aerin Lauder Zinterhofer, in her capacity as trustee of the 2008 Descendants Trust, became party to the Stockholders' Agreement. On September 16, 2026, ELZ became a trustee of the 2008 Descendants Trust (the "Trustee Appointment"), and, in compliance with the requirements of the Stockholders' Agreement, became party to the Stockholders' Agreement, in his capacity as trustee of the 2008 Descendants Trust. By virtue of the Trustees, in their capacity as trustees of the 2008 Descendants Trust, becoming party to the Stockholders' Agre…

Item 4, purpose of the transaction: Item 4 is hereby amended and supplemented to add the following: On September 16, 2026, SGF FANG sold an aggregate of 9,079,675 shares of Common Stock at a price of $205.26 per share pursuant to Rule 144 under the Securities Act of 1933, as amended (the "September 16, 2026 Sale"). In connection with the September 16, 2026 Sale, SGF FANG is subject to a lock-up period from September 16, 2026 through the date 30 days after September 16, 2026, during which SGF FANG may not sell any shares of Common Stock without the mutual agreement of SGF FANG and Morgan Stanley & Co. LLC.

Item 4, purpose of the transaction: Item 4 of the Statement is hereby amended and supplemented as follows: The information set forth or incorporated in Item 3 and Item 6 of this Amendment is hereby incorporated by reference in its entirety into this Item 4. On September 11, 2026, Blockchain Fund exercised Cash Pre-Funded Warrants for 1,000,000 Class A Common Shares at an exercise price of $0.001 per share, for an aggregate cash payment to the Issuer of $1,000. Other than as described in this Item 4, none of the Reporting Persons presently has any additional plans or proposals that relate to or that would result in any of the transactions or other matters specified in clauses (a) through (j) of Item 4 of this Schedule 13D, bu…